Helen Pervanas, PharmD

RSVpreF is currently the only FDA-approved RSV vaccine for pregnant individuals.

Pharmacists should review the medications of patients with multiple sclerosis regularly to assess drug-drug interactions.

In a clinical trial, 86.4% of patients on semaglutide achieved a 5% weight loss at week 68 compared to 31.5% with placebo.